LOS ANGELES CAPITAL MANAGEMENT LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$24,808
-10.1%
19,083
+21.8%
0.00%
Q1 2023$27,581
-51.4%
15,671
-13.3%
0.00%
Q4 2022$56,759
-89.3%
18,076
-83.3%
0.00%
-100.0%
Q3 2022$531,000
+172.3%
108,343
+130.2%
0.00%
+200.0%
Q2 2022$195,000
-28.6%
47,0580.0%0.00%0.0%
Q1 2022$273,000
-22.7%
47,0580.0%0.00%0.0%
Q4 2021$353,000
-34.9%
47,058
-21.8%
0.00%
-50.0%
Q3 2021$542,000
-24.7%
60,1530.0%0.00%
-33.3%
Q2 2021$720,000
-9.8%
60,153
-5.5%
0.00%
-25.0%
Q1 2021$798,000
-69.4%
63,653
-61.9%
0.00%
-63.6%
Q4 2020$2,606,000
+274.4%
166,973
+126.8%
0.01%
+266.7%
Q3 2020$696,000
+74.4%
73,612
+65.4%
0.00%
+50.0%
Q2 2020$399,000
-73.8%
44,492
-50.4%
0.00%
-75.0%
Q3 2018$1,520,000
+19.3%
89,6860.0%0.01%
+14.3%
Q2 2018$1,274,000
+43.6%
89,686
+92.1%
0.01%
+40.0%
Q1 2018$887,000
+265.0%
46,686
+214.5%
0.01%
+400.0%
Q4 2017$243,000
-31.4%
14,846
-34.2%
0.00%
-66.7%
Q1 2015$354,000
+58.7%
22,560
+54.4%
0.00%
+50.0%
Q2 2014$223,00014,6100.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,400,000$12,320,0004.56%
EcoR1 Capital, LLC 2,568,119$22,599,0004.01%
FIC CAPITAL INC 960,338$8,451,0003.48%
Opaleye Management Inc. 580,000$5,104,0002.13%
DAFNA Capital Management LLC 225,000$1,980,0001.41%
RA Capital Management 1,250,000$11,000,0001.26%
Iguana Healthcare Management, LLC 215,000$1,892,0001.07%
Avoro Capital Advisors LLC 800,000$7,040,0000.89%
WASATCH ADVISORS LP 6,930,535$60,989,0000.85%
Cormorant Asset Management, LP 400,000$3,520,0000.58%
View complete list of SANGAMO THERAPEUTICS INC shareholders